Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort descending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort descending Business Functional Area Date Posted
Senior Analyst - Data & Products Hyderabad (Office) India Operations CTS Marketing May 22, 2024
HSE Facilities Maintenances Specialist Cambridge (USA) USA Operations CTS Facilities & Administration May 22, 2024
AS&T Specialist İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Sep 03, 2024
Senior Specialist, Master Batch Record (MBR) Design Indianapolis USA Operations CTS Technology Transformation May 28, 2024
Sr. Special. DDIT IES O365 eDLS Ops Hyderabad (Office) India Operations CTS Technology Transformation May 29, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA SF) Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
S/4HANA ABAP Technical Expert INSURGENTES Mexico Operations CTS Technology Transformation Sep 03, 2024
Analyst Hyderabad (Office) India Operations CTS Marketing Jun 02, 2024
Maintenance Technician (Mechatronics) Schaftenau Austria Operations Innovative Medicines Technical Operations Sep 03, 2024
Change Control Coordinator Hyderabad (Office) India Operations Innovative Medicines Technical Operations Jun 03, 2024
Sourcing Manager R&D, Drug Development Hyderabad (Office) India Operations CTS Procurement Jun 04, 2024
QC Analyst IV - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Jun 04, 2024
Enterprise Architecture and Integration Director for Commercial Areas INSURGENTES Mexico Operations CTS Technology Transformation Jun 04, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development Jun 06, 2024
Manufacturing Systems Expert (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 21, 2024
Pharmaziepraktikant (w/m/d) im Quality Management ab Mai 2025 Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Operations Innovative Medicines Others Oct 22, 2024
Labortechniker / QC Analyst II im Mikrobiologischen Labor (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 23, 2024
AS&T Expert Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
Labortechniker / QC Analyst II (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
AS&T Specialist Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
Process Expert (m/f/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 24, 2024
Chemical Expert Fire Brigade Kundl Austria Operations Innovative Medicines Facilities & Administration Oct 24, 2024
Senior Process Expert (m/f/d) - Temporary Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 25, 2024
QC Specialist II Schaftenau Austria Operations Innovative Medicines Quality Oct 25, 2024
Site Equipment & CQV Lead Indianapolis USA Operations Innovative Medicines Technical Operations Sep 03, 2024
Sr. Spec. DDIT IES NetSec Engg Hyderabad (Office) India Operations CTS Technology Transformation Apr 16, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC Ent Arch Digit Sec Hyderabad (Office) India Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC VulnSvcs role Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Sr. Bus. Analyst DDIT US&I CPM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Mgr. DDIT Svc.Mgt China Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Svc.Mgt CN Data Platf Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Sol.Del. China Data Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sachkundige Person Radiopharmazie (d/w/m) Munich (AAA Germany GmbH) Germany Operations Innovative Medicines Quality Apr 22, 2024
Sr. Spec. DDIT IES NW Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 22, 2024
Snr.Spec. DDIT APD Sol Del Visualization Hyderabad (Office) India Operations CTS Technology Transformation Apr 22, 2024
Sr. Specialist DDIT APD ERP PlatformTech Hyderabad (Office) India Operations CTS Technology Transformation Apr 23, 2024
Senior Medical Information Manager 2 Dublin (Novartis Corporate Center (NOCC)) Ireland Operations CTS Research & Development Apr 23, 2024
Innovation Manager Hyderabad (Office) India Operations Innovative Medicines Quality Apr 24, 2024
Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 24, 2024
Automatiker im Schichtbetrieb - Novartis, Stein ( Galenic). Stein Aargau Switzerland Operations Innovative Medicines Technical Operations Oct 17, 2024
Production Operator Stein Aargau Switzerland Operations Innovative Medicines Technical Operations Apr 16, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Contracts Manager - LDC Solutions Design Manager - Barcelona Gran Vía Spain Operations CTS Marketing Sep 03, 2024
Equipment Operator Stein Aargau Switzerland Operations Innovative Medicines Technical Operations May 28, 2024
Validation lead İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Jun 07, 2024
SCM Sourcing Officer Kundl Austria Operations Innovative Medicines Technical Operations Jun 26, 2024
Automatiker im Schichtbetrieb Stein Aargau Switzerland Operations Innovative Medicines Technical Operations Jul 11, 2024
Senior Process Expert / Manufacturing Science and Technology İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Jul 19, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only